Crossmark

Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study

Published Online: 2024-10-31

Published Print: 2025-06

Authors

Castelli, Roberto https://orcid.org/0009-0003-6756-9074
Manetti, Roberto

Sechi, Gemma Lisa

Deliliers, Giorgio Lambertenghi

Gidaro, Antonio
License Information

Text and Data Mining valid from 2024-10-31

Version of Record valid from 2024-10-31
More Information

Article History

Received: 1 August 2024

Accepted: 21 October 2024

First Online: 31 October 2024

Declarations

:

: The study was approved by local ethical comitee. The study respects human rights, while animals rights respect is not applicable. All authors decleare conflicts of interests.

Document is current